Vivos Therapeutics Shares Surge After $4.5 Million Debt Conversion Fuels Nasdaq Optimism
Vivos Therapeutics shares surged Friday after the sleep apnea device company said its main lender will exchange as much as $4.5 million in debt for equity. The company said the deal is aimed at reducing balance sheet stress and helping it stay on the Nasdaq.